Amsino acquires MedXL to expand North American manufacturing

Amsino International has acquired the assets of MedXL, including manufacturing facilities in Montreal, Canada, adding two FDA- and Health Canada-registered facilities and a distribution center. The acquisition doubles Amsino's syringe production capacity to over 500 million units annually.

“This acquisition aligns with our strategy to strengthen North American manufacturing and improve supply chain resilience in today's complex geopolitical climate.”g-medtech.com

• 1 source
• g-medtech.comAmsino Acquires MedXL to Expand North American Manufacturing and Double Syringe Production Capacity - News CenterNov 26, 2024

Summarized from public sources; check the original articles before acting on it.